πŸ‡ΊπŸ‡Έ FDA
Patent

US 8455688

HDAC inhibitors

granted A61PA61P1/16A61P29/00

Quick answer

US patent 8455688 (HDAC inhibitors) held by Lixte Biotechnology, Inc. expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/16, A61P29/00, A61P3/10, A61P31/18